Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vergence Naturals is a Canadian bioceutical company and a wholly-owned subsidiary of Abattis Bioceuticals Corp. The company specializes in the development, marketing, and distribution of natural health products, with a particular focus on cannabinoid-enhanced nutraceuticals. Its flagship product, Comfort, is a proprietary formulation designed to address chronic pain and inflammation by targeting the endocannabinoid system using botanical extracts such as Alpinia galanga and Capsicum annuum. Vergence Naturals also operates an e-commerce platform that serves as a retail gateway for its own product lines as well as third-party natural health brands. The company was a central component of Abattis's vertical integration strategy, bridging the gap between laboratory formulation and consumer retail.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vergence Naturals.